Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 38


Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib.

Keizman D, Sarid D, Lee JL, Sella A, Gottfried M, Hammers H, Eisenberger MA, Carducci MA, Sinibaldi V, Neiman V, Rosenbaum E, Peer A, Neumann A, Mermershtain W, Rouvinov K, Berger R, Yildiz I.

Oncologist. 2016 Jul 5. pii: theoncologist.2015-0428. [Epub ahead of print]


Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma.

Keizman D, Ish-Shalom M, Sella A, Gottfried M, Maimon N, Peer A, Hammers H, Eisenberger MA, Sinibaldi V, Neiman V, Rosenbaum E, Sarid D, Mermershtain W, Rouvinov K, Berger R, Carducci MA.

Clin Genitourin Cancer. 2016 Apr 27. pii: S1558-7673(16)30102-1. doi: 10.1016/j.clgc.2016.04.012. [Epub ahead of print]


Adjuvant brachytherapy for Stage IB Grade 2 endometrial carcinoma: Multivariate analysis of a single institution experience.

Tokar M, Meirovich M, Bobilev D, Mermershtain W.

Indian J Med Paediatr Oncol. 2016 Apr-Jun;37(2):112-5. doi: 10.4103/0971-5851.180148.


Primitive Neuroectodermal Tumor of the Kidney: A Case Report.

Rouvinov K, Yakobson A, Ariad S, Mermershtain W.

Clin Genitourin Cancer. 2015 Aug;13(4):e333-6. doi: 10.1016/j.clgc.2015.02.005. Epub 2015 Feb 21. No abstract available.


Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?

Keizman D, Rouvinov K, Sella A, Gottfried M, Maimon N, Kim JJ, Eisenberger MA, Sinibaldi V, Peer A, Carducci MA, Mermershtain W, Leibowitz-Amit R, Weitzen R, Berger R.

Cancer Res Treat. 2016 Jan;48(1):281-7. doi: 10.4143/crt.2014.289. Epub 2015 Mar 5.


Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.

Livne-Segev D, Gottfried M, Maimon N, Peer A, Neumann A, Hayat H, Kovel S, Sella A, Mermershtain W, Rouvinov K, Boursi B, Weitzen R, Berger R, Keizman D.

Isr Med Assoc J. 2014 Jun;16(6):347-51.


Enzalutamide in metastatic prostate cancer before chemotherapy.

Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators.

N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1.


Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib.

Keizman D, Gottfried M, Ish-Shalom M, Maimon N, Peer A, Neumann A, Hammers H, Eisenberger MA, Sinibaldi V, Pili R, Hayat H, Kovel S, Sella A, Boursi B, Weitzen R, Mermershtain W, Rouvinov K, Berger R, Carducci MA.

Oncologist. 2014 Jan;19(1):51-60. doi: 10.1634/theoncologist.2012-0335. Epub 2013 Dec 5.


Alpha emitter radium-223 and survival in metastatic prostate cancer.

Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators.

N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.


Fatal liver failure in a patient treated with sunitinib for renal cell carcinoma.

Mermershtain W, Lazarev I, Shani-Shrem N, Ariad S.

Clin Genitourin Cancer. 2013 Mar;11(1):70-2. doi: 10.1016/j.clgc.2012.09.005. Epub 2012 Oct 12. No abstract available.


Successful treatment of mediastinal seminoma in a hemodialysis patient.

Lazarev I, Bogomolni L, Shani-Shrem N, Shnaider A, Ariad S, Mermershtain W.

Onkologie. 2012;35(5):275-8. doi: 10.1159/000338481. Epub 2012 Apr 24.


Localization of PKCη in cell membranes as a predictor for breast cancer response to treatment.

Karp G, Abu-Ghanem S, Novack V, Mermershtain W, Ariad S, Sion-Vardy N, Livneh E.

Onkologie. 2012;35(5):260-6. doi: 10.1159/000338443. Epub 2012 Apr 24.


Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model.

Vainas O, Ariad S, Amir O, Mermershtain W, Vainstein V, Kleiman M, Inbar O, Ben-Av R, Mukherjee A, Chan S, Agur Z.

Br J Cancer. 2012 Aug 21;107(5):814-22. doi: 10.1038/bjc.2012.316. Epub 2012 Jul 19.


Is prostate cancer screening justified in the Bedouin population?

Abdallah M, Lazarev I, Ariad S, Mermershtain W.

Onkologie. 2009 May;32(5):260-2. doi: 10.1159/000212073. Epub 2009 Apr 20.


Ethnicity and its significance in the pathobiology of prostatic carcinoma in Southern Israel.

Sion-Vardy N, Priel-Cohen Z, Mermershtain W, Neulander E, Benharroch D.

Urol Oncol. 2008 Jan-Feb;26(1):31-6. doi: 10.1016/j.urolonc.2007.01.023. Epub 2007 Nov 19.


Serous papillary adenocarcinoma of the rete testis: unusual ultrasonography and pathological findings.

Mermershtain W, Vardi N, Gusakova I, Klein J.

J Cancer Res Ther. 2007 Jan-Mar;3(1):37-9.


Pulmonary sarcoidosis mimicking metastases in breast cancer patients.

Gusakova I, Lavrenkov K, Ariad S, Mermershtain W.

Onkologie. 2007 Jun;30(6):327-8. No abstract available.


Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.

Chernobelski P, Lavrenkov K, Rimar D, Riesenberg K, Schlaeffer F, Ariad S, Mermershtain W.

Chemotherapy. 2006;52(4):185-9. Epub 2006 May 2.


Cutaneous photosensitivity induced by paclitaxel and trastuzumab therapy associated with aberrations in the biosynthesis of porphyrins.

Cohen AD, Mermershtain W, Geffen DB, Schoenfeld N, Mamet R, Cagnano E, Cohen Y, Halevy S.

J Dermatolog Treat. 2005 Feb;16(1):19-21.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk